VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹854 Cr | ₹716 Cr | ₹627 Cr | ₹601 Cr | ₹579 Cr |
What is the latest Total Liabilities ratio of VENUS REMEDIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹854 Cr |
| Mar2025 | ₹716 Cr |
| Mar2024 | ₹627 Cr |
| Mar2023 | ₹601 Cr |
| Mar2022 | ₹579 Cr |
How is Total Liabilities of VENUS REMEDIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹854 Cr | 19.28 | |
| Mar2025 | ₹716 Cr | 14.18 | |
| Mar2024 | ₹627 Cr | 4.28 | |
| Mar2023 | ₹601 Cr | 3.79 | |
| Mar2022 | ₹579 Cr | - | |
Compare Total Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,051.3 Cr | -7.5% | -14% | 243.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -1.5% | 15.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,223.0 Cr | -3% | 8.3% | 52.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹183,453.0 Cr | -2.2% | -1.5% | 35% | Stock Analytics | |
| CIPLA | ₹109,849.0 Cr | -0.6% | -4.9% | -13% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,591.8 Cr | 0.2% | -3.9% | -11.8% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -7.5% |
-14% |
243.3% |
| SENSEX | -1.6% |
-4.7% |
-8.3% |
You may also like the below Video Courses